Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells

Evidence-based Complementary and Alternative Medicine - Egypt
doi 10.1155/2016/7028289
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Qingyihuaji Formula Reverses Gemcitabine Resistant Human Pancreatic Cancer Through Regulate LncRNA AB209630/miR-373/EphB2-NANOG Signals

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

Author Correction: PRMT1 Promotes Pancreatic Cancer Growth and Predicts Poor Prognosis

Cellular Oncology
MedicineCancer ResearchOncologyMolecular Medicine
2019English

Cancer Stem Cells in Pancreatic Cancer

Cancers
Cancer ResearchOncology
2010English

Over-Expression of Nanog Predicts Tumor Progression and Poor Prognosis in Colorectal Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

Co-Expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas

Scientific Reports
Multidisciplinary
2018English

Targeting Pancreatic Cancer Stem Cells

Journal of Cancer Sciences
2015English

ERO1α Promotes Hypoxic Tumor Progression and Is Associated With Poor Prognosis in Pancreatic Cancer

Oncotarget
Oncology
2019English

Glycolysis in Panc-1 Human Pancreatic Cancer Cells Is Inhibited by Everolimus

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2012English

Paclitaxel-Induced Apoptosis Is Blocked by Camptothecin in Human Breast and Pancreatic Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy